PATENT CLAIM ANALYSIS

Application Number: 15984055
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising an NSAID such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of conditions such as pain.

Claim (Index 15):
The method of  claim 3 , wherein, 120 minutes after oral administration of the solid dosage form, the dissolution of meloxicam is at least about 5 times that of the reference dosage form.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 93.0
- Lexical Diversity: 1.35135
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15902770', '15797955', '15132130', '15936176', '15976800']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7745269754625554
- 35 USC 102 Novelty (BERT): 0.5368933156213528
- Combined Prediction Score: 0.7507636094784352
- Mean Citation Score: 322.9805780000001
- Max Citation Score: 336.5019999999999
- Similarity Product: 192.4255404049157

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test